198 related articles for article (PubMed ID: 20230618)
1. pEPito: a significantly improved non-viral episomal expression vector for mammalian cells.
Haase R; Argyros O; Wong SP; Harbottle RP; Lipps HJ; Ogris M; Magnusson T; Vizoso Pinto MG; Haas J; Baiker A
BMC Biotechnol; 2010 Mar; 10():20. PubMed ID: 20230618
[TBL] [Abstract][Full Text] [Related]
2. Generation of a tumor- and tissue-specific episomal non-viral vector system.
Haase R; Magnusson T; Su B; Kopp F; Wagner E; Lipps H; Baiker A; Ogris M
BMC Biotechnol; 2013 Jun; 13():49. PubMed ID: 23734827
[TBL] [Abstract][Full Text] [Related]
3. Sustained gene expression in the retina by improved episomal vectors.
Calado SM; Oliveira AV; Machado S; Haase R; Silva GA
Tissue Eng Part A; 2014 Oct; 20(19-20):2692-8. PubMed ID: 24684370
[TBL] [Abstract][Full Text] [Related]
4. The β-globin Replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells.
Stavrou EF; Lazaris VM; Giannakopoulos A; Papapetrou E; Spyridonidis A; Zoumbos NC; Gkountis A; Athanassiadou A
Sci Rep; 2017 Jan; 7():40673. PubMed ID: 28106085
[TBL] [Abstract][Full Text] [Related]
5. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells.
Wang X; Xu Z; Tian Z; Zhang X; Xu D; Li Q; Zhang J; Wang T
J Cell Mol Med; 2017 Nov; 21(11):3044-3054. PubMed ID: 28557288
[TBL] [Abstract][Full Text] [Related]
6. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.
Argyros O; Wong SP; Niceta M; Waddington SN; Howe SJ; Coutelle C; Miller AD; Harbottle RP
Gene Ther; 2008 Dec; 15(24):1593-605. PubMed ID: 18633447
[TBL] [Abstract][Full Text] [Related]
7. Enhancing expression level and stability of transgene mediated by episomal vector via buffering DNA methyltransferase in transfected CHO cells.
Wang XY; Yi DD; Wang TY; Wu YF; Chai YR; Xu DH; Zhao CP; Song C
J Cell Biochem; 2019 Sep; 120(9):15661-15670. PubMed ID: 31074065
[TBL] [Abstract][Full Text] [Related]
8. Shortened nuclear matrix attachment regions are sufficient for replication and maintenance of episomes in mammalian cells.
Wang XY; Zhang X; Wang TY; Jia YL; Xu DH; Yi DD
Mol Biol Cell; 2019 Oct; 30(22):2761-2770. PubMed ID: 31509492
[TBL] [Abstract][Full Text] [Related]
9. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
10. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
11. Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation.
Jenke AC; Scinteie MF; Stehle IM; Lipps HJ
Mol Biol Rep; 2004 Jun; 31(2):85-90. PubMed ID: 15293783
[TBL] [Abstract][Full Text] [Related]
12. Conventional plasmid DNAs with a CpG-containing backbone achieve durable transgene expression in mouse liver.
Suzuki T; Wakao Y; Goda T; Kamiya H
J Gene Med; 2020 Jan; 22(1):e3138. PubMed ID: 31696985
[TBL] [Abstract][Full Text] [Related]
13. Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells.
Xu ZJ; Jia YL; Wang M; Yi DD; Zhang WL; Wang XY; Zhang JH
Bioengineered; 2019 Dec; 10(1):548-560. PubMed ID: 31668126
[TBL] [Abstract][Full Text] [Related]
14. Controlled removal of a nonviral episomal vector from transfected cells.
Rupprecht S; Hagedorn C; Seruggia D; Magnusson T; Wagner E; Ogris M; Lipps HJ
Gene; 2010 Oct; 466(1-2):36-42. PubMed ID: 20621169
[TBL] [Abstract][Full Text] [Related]
15. CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells.
Williams S; Mustoe T; Mulcahy T; Griffiths M; Simpson D; Antoniou M; Irvine A; Mountain A; Crombie R
BMC Biotechnol; 2005 Jun; 5():17. PubMed ID: 15935093
[TBL] [Abstract][Full Text] [Related]
16. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
[TBL] [Abstract][Full Text] [Related]
17. Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides.
Hodges BL; Taylor KM; Joseph MF; Bourgeois SA; Scheule RK
Mol Ther; 2004 Aug; 10(2):269-78. PubMed ID: 15294174
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
19. Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression.
Krinner S; Heitzer A; Asbach B; Wagner R
Hum Gene Ther; 2015 Dec; 26(12):826-40. PubMed ID: 26414116
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.
Mulia GE; Picanço-Castro V; Stavrou EF; Athanassiadou A; Figueiredo ML
Hum Gene Ther; 2021 Oct; 32(19-20):1076-1095. PubMed ID: 34348480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
